Abbott Laboratories (ABT)
125.65
-0.13
(-0.10%)
USD |
NYSE |
Dec 31, 13:06
Abbott Laboratories Cash from Investing (Quarterly): -457.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| ResMed, Inc. | -52.58M |
| Stryker Corp. | -321.00M |
| Edwards Lifesciences Corp. | -661.50M |
| Intuitive Surgical, Inc. | 401.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.787B |
| Cash from Financing (Quarterly) | -1.76B |
| Free Cash Flow | 6.917B |
| Free Cash Flow Per Share (Quarterly) | 1.310 |
| Free Cash Flow to Equity (Quarterly) | 2.787B |
| Free Cash Flow to Firm (Quarterly) | 2.382B |
| Free Cash Flow Yield | 3.15% |